ES2749181T3 - Anti-GCC antibody molecules and use thereof to test for susceptibility to GCC-targeted therapy - Google Patents

WO2017136693A1 - Gcc-targeted antibody-drug conjugates - Google Patents

WO2011050242A1 - Anti-gcc antibody molecules and related compositions and methods - Google Patents

US8785600B2 - Anti-GCC antibody molecules and related compositions and methods - Google Patents

WO2011050242A1 - Anti-gcc antibody molecules and related compositions and methods - Google Patents

US8785600B2 - Anti-GCC antibody molecules and related compositions and methods - Google Patents

WO2017136693A1 - Gcc-targeted antibody-drug conjugates - Google Patents

WO2017136693A1 - Gcc-targeted antibody-drug conjugates - Google Patents

US10941211B2 - Anti-GCC antibody molecules and related compositions and methods - Google Patents

WO2011050242A1 - Anti-gcc antibody molecules and related compositions and methods - Google Patents

US8785600B2 - Anti-GCC antibody molecules and related compositions and methods - Google Patents

WO2011050242A1 - Anti-gcc antibody molecules and related compositions and methods - Google Patents

WO2017136693A1 - Gcc-targeted antibody-drug conjugates - Google Patents

ES2749181T3 - Anti-GCC antibody molecules and use thereof to test for susceptibility to GCC-targeted therapy - Google Patents

ES2749181T3 - Anti-GCC antibody molecules and use thereof to test for susceptibility to GCC-targeted therapy - Google Patents